Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Guardado en:
Detalles Bibliográficos
Autores principales: John Yeakel, MD, Aarthi Kannan, BA, Nicole Hook Rattigan, PhD, Maki Yamamoto, MD, Alexey Aleshin, MD, MBA, Jeremy P. Harris, MPhil, MD, Ling Gao, MD, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:83c88c6092e54f0f84f262e3833ad7ea
record_format dspace
spelling oai:doaj.org-article:83c88c6092e54f0f84f262e3833ad7ea2021-11-26T04:34:31ZBespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient2352-512610.1016/j.jdcr.2021.10.025https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352512621007785https://doaj.org/toc/2352-5126John Yeakel, MDAarthi Kannan, BANicole Hook Rattigan, PhDMaki Yamamoto, MDAlexey Aleshin, MD, MBAJeremy P. Harris, MPhil, MDLing Gao, MD, PhDElsevierarticlecirculating tumor DNAhypofractionated radiationMerkel cell carcinomaT-VECDermatologyRL1-803ENJAAD Case Reports, Vol 18, Iss , Pp 94-98 (2021)
institution DOAJ
collection DOAJ
language EN
topic circulating tumor DNA
hypofractionated radiation
Merkel cell carcinoma
T-VEC
Dermatology
RL1-803
spellingShingle circulating tumor DNA
hypofractionated radiation
Merkel cell carcinoma
T-VEC
Dermatology
RL1-803
John Yeakel, MD
Aarthi Kannan, BA
Nicole Hook Rattigan, PhD
Maki Yamamoto, MD
Alexey Aleshin, MD, MBA
Jeremy P. Harris, MPhil, MD
Ling Gao, MD, PhD
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
format article
author John Yeakel, MD
Aarthi Kannan, BA
Nicole Hook Rattigan, PhD
Maki Yamamoto, MD
Alexey Aleshin, MD, MBA
Jeremy P. Harris, MPhil, MD
Ling Gao, MD, PhD
author_facet John Yeakel, MD
Aarthi Kannan, BA
Nicole Hook Rattigan, PhD
Maki Yamamoto, MD
Alexey Aleshin, MD, MBA
Jeremy P. Harris, MPhil, MD
Ling Gao, MD, PhD
author_sort John Yeakel, MD
title Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_short Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_full Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_fullStr Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_full_unstemmed Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
title_sort bespoke circulating tumor dna as a biomarker for treatment response in a refractory merkel cell carcinoma patient
publisher Elsevier
publishDate 2021
url https://doaj.org/article/83c88c6092e54f0f84f262e3833ad7ea
work_keys_str_mv AT johnyeakelmd bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT aarthikannanba bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT nicolehookrattiganphd bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT makiyamamotomd bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT alexeyaleshinmdmba bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT jeremypharrismphilmd bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
AT linggaomdphd bespokecirculatingtumordnaasabiomarkerfortreatmentresponseinarefractorymerkelcellcarcinomapatient
_version_ 1718409851165474816